pancreate cancer

Biotech

Fortress joins KRAS race through Columbia University deal

Fortress has set up a new biotech, Oncogenuity, to advance the preclinical asset and work to generate more oligonucleotides from the platform.
Nick Paul Taylor May 8, 2020 8:45am

Five Prime taps Genentech vet Civik to take the helm

Apr 14, 2020 10:15am

BioNTech snaps up MabVax asset, labs, eyeing San Diego R&D site

May 8, 2019 9:35am

New Year biotech IPO hopefuls gun for $369M

Jan 2, 2018 4:56am

CRUK, NCI fund Ras inhibitor tests, create commercial path

Apr 19, 2017 3:21am